S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ALLR Allarity Therapeutics Inc

1.46

0.10 (7.35%)

Pre Market

Last Updated: 20:55:35

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Saturday 25 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Tuesday 19 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Friday 15 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

More Allarity Therapeutics Inc News Articles

Vontobel Financial Produ...

Vertex Pharmac Dl 01

Amundi ETF MSCI World Ex...

Societe Generale Effekten

Wisdomtree Natural Gas 3...

Frank Temp ICAV Frank ST...

Deutsche Rohstoff

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions